Emmanuelle Charpentier and Jennifer Doudna win the Nobel Prize for groundbreaking CRISPR discovery
Emmanuelle Charpentier and Jennifer Doudna have won the Nobel Prize in chemistry for their groundbreaking work using CRISPR/Cas9 in gene editing.
Charpentier and Doudna, now one of the busiest scientists/entrepreneurs in the Bay Area, birthed a whole new research field when they published their work on an easily accessible technology for gene editing.
The breakthrough swiftly inspired hundreds of academic studies and spawned a wave of biotech startups like Intellia, CRISPR Therapeutics and others that sought to apply the tech to the development of new therapies. And now those upstarts are being followed by a whole new wave of companies that are applying improvements on the duo’s foundational work.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 107,400+ biopharma pros reading Endpoints daily — and it's free.